Dianthus Therapeutics Stock (NASDAQ: DNTH) stock price, news, charts, stock research, profile.
Open | $26.480 |
Close | - |
Volume / Avg. | 68.637K / 166.659K |
Day Range | 23.915 - 26.480 |
52 Wk Range | 6.580 - 33.770 |
Market Cap | $718.308M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 9.16% |
Days to Cover | 11.65 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dianthus Therapeutics (NASDAQ: DNTH) through any online brokerage.
Other companies in Dianthus Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Cogent Biosciences (NASDAQ:COGT), Sage Therapeutics (NASDAQ:SAGE), Tango Therapeutics (NASDAQ:TNGX) and Pharming (NASDAQ:PHAR).
The latest price target for Dianthus Therapeutics (NASDAQ: DNTH) was reported by Wedbush on Friday, May 10, 2024. The analyst firm set a price target for 38.00 expecting DNTH to rise to within 12 months (a possible 55.26% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Dianthus Therapeutics (NASDAQ: DNTH) is $24.475 last updated Today at May 10, 2024 at 3:16 PM EDT.
There are no upcoming dividends for Dianthus Therapeutics.
Dianthus Therapeutics’s Q2 earnings are confirmed for Saturday, August 3, 2024.
There is no upcoming split for Dianthus Therapeutics.
Dianthus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.